Close
Almac
Achema middle east

Industry Reports

The Way Forward for the Healthcare Data Ecosystem

The transformation of worldwide healthcare by way of digital innovation has reached a very critical inflection point in which the potential advantages of data-driven medicine should be carefully balanced against the fundamental ethical principles as well as privacy rights....

Pharma Sector Reactions to US-EU Trade Framework Deal

The United States and the EU have, on August 21, 2025, announced a joint statement related to the trade framework agreement on reciprocal, fair, and balanced trade. This landmark trade US-EU trade framework agreement happens to mark a major...

Trump Executive Order to Cover 26 Drugs Critical to Health

US president Donald Trump has gone on to direct the health department to draw a list of drugs that are deemed to be essential and stockpile the active pharmaceutical ingredients (APIs) that they require. His executive order is going...

Rise of Pharma Eco-Labeling and Carbon Footprint Tracking

The pharmaceutical sector, which has been long governed by stringent safety and quality protocols, is now facing a new layer of responsibility, and that is environmental stewardship. As the worldwide attention moves towards climate change, sustainability, and also corporate accountability,...

Packaging Market for Temperature-Sensitive Pharmaceuticals

In the complex and unforgiving world of pharmaceutical logistics, every degree matters. The temperature-controlled pharma packaging market happens to stand as a silent guardian of product integrity, making sure that the life-saving drugs, vaccines, biologics, and specialty formulations survive the...

Clinical Trial Supplies Market Worth $8.18 Billion by 2030

The market for clinical trial supplies is about to change a lot because there is a growing need for new ways to help people with their health and because medical research is making progress. As the world changes, the...

AI in Genomics Market – Setting Pace for Vast Genomic Data

There is no shred of doubt that artificial intelligence in genomics is indeed reshaping the healthcare spectrum, offering unmatched opportunities to decode the intricacies of the human genome. Apparently, in 2024, the global artificial intelligence and genomics market was valued...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »